Providence Health & Services - Oregon

Oregon Health Authority - Antimicrobial Gold Award, Top 100 Oncology Hospitals in the U.S. 2024 - Becker's Hospital Review, American College of Radiology (ACR), Commission on Cancer (CoC) Accreditation - American College of Surgeons (ACS), National Accreditation Program for Breast Centers - American College of Surgeons (ACS), National Accreditation Program for Rectal Cancer Programs - American College of Surgeons (ACS), Accreditation Program for Excellence - American Society for Radiation Oncology (ASTRO)®, Foundation for the Accreditation of Cellular Therapy (FACT), Accountable Care Organizations (ACO) Accreditation - National Committee for Quality Assurance (NCQA), Pancreatic Center of Excellence - National Pancreas Foundation (NPF), Quality Oncology Practice Initiative (QOPI) Certification - American Society of Clinical Oncology (ASCO)

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science. New studies at Providence Cancer Institute offer hope to patients with limited treatment options. Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine. Providence cancer research provides options, and hope, for patients seeking advanced procedures and therapies. We’re proud of our long history of pioneering clinical trials, research and evidence-based therapies. We established the first cancer-care center west of the Mississippi. We also have over 90 years of radiation research. Among other groundbreaking firsts: We led the international trial of the first immunotherapy to be approved for patients with melanoma, as well as the first successful gene-engineered T-cell therapy for metastatic pancreatic cancer. As a Providence patient, you have the opportunity to participate in – or benefit from – the 1,300 new clinical trials that begin each year.